Skip to Main Content

Browse issues

The Journal of Clinical Endocrinology & Metabolism Cover Image for Volume 104, Issue 3
Volume 104, Issue 3
March 2019
ISSN 0021-972X
EISSN 1945-7197

Volume 104, Issue 3, March 2019

Case Reports

Marco Dauriz and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 773–778, https://doi.org/10.1210/jc.2018-02007

Pasireotide rescue therapy failed to prevent hypoglycemic episodes in a rare case of adult nesidioblastosis and masked insulinoma relapse.

Carla Colombo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 779–784, https://doi.org/10.1210/jc.2018-01836

Primitive adrenal insufficiency was diagnosed in patients on lenvatinib or vandetanib and prompt improvement in the degree of fatigue was documented upon cortisone acetate replacement treatment.

Giovanna Motta and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 819–822, https://doi.org/10.1210/jc.2018-01702

The co-prescription of testosterone and SGLT2i in patients with hypogonadism and T2DM, conditions frequently associated, may induce erythrocytosis and should prompt clinicians to a careful monitoring.

Raffaella Labbadia and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 823–826, https://doi.org/10.1210/jc.2018-01193

We report a patient with pseudohypoparathyroidism type Ia and renal failure due to reasons independent of the primary disease, with normalized biochemical abnormalities after renal transplantation.

Anna Malczewska and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 867–872, https://doi.org/10.1210/jc.2018-01804

We describe the utility of a blood-based multigene PCR neuroendocrine measurement (NETest) to detect hepatic micrometastases in a patient with negative blood biomarkers and anatomical/functional imaging.

Nivedita Patni and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 957–960, https://doi.org/10.1210/jc.2018-01331

We present an autopsy description of congenital generalized lipodystrophy, type 4. Fat cells interdigitating cardiac muscle fibers and fibro-fatty infiltration could explain life-threatening arrhythmias.

Mini-Review

Marily Theodoropoulou and Martin Reincke
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 925–933, https://doi.org/10.1210/jc.2018-02080

A review on corticotroph tumor-directed pharmacological agents and their rationale and perspective for the treatment of Cushing disease.

Clinical Research Articles

Sherry Wu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 629–638, https://doi.org/10.1210/jc.2018-01528

Single oral doses up to 800 mg of 11β-MNTDC are well tolerated and resulted in increases in serum 11β-MNT (an androgen with progestational activity) and suppression of testosterone in healthy men.

Tae Jung Oh and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 639–646, https://doi.org/10.1210/jc.2018-01239

High body-weight variability was associated with higher mortality in this 16-year prospective cohort study.

Johan Onslev and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 647–657, https://doi.org/10.1210/jc.2018-01349

We show that a selective β2-adrenergic agonist increases leg glucose uptake and clearance at rest, but decreases clearance during exercise in healthy active young men.

Anthony J Swerdlow and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 658–664, https://doi.org/10.1210/jc.2018-01133

In a five-country cohort of 10,403 patients treated with recombinant growth hormone, meningioma risk was greatly raised in relation to radiotherapy, but not apparently related to growth hormone.

Ying Yang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 665–673, https://doi.org/10.1210/jc.2018-00619

High glucose-enhanced FTO expression resulted in an m6A decrease. FTO induced FOXO1, G6PC, and DGAT2 expression and was associated with glucose metabolism.

Berenice Segrestin and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 688–696, https://doi.org/10.1210/jc.2018-01169

Iron could limit AT expansion by its link with lipid storage gene expression. Overfeeding increased AT lipid storage gene expression and modulated iron genes expression.

Yuanlin Dong and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 697–706, https://doi.org/10.1210/jc.2018-01119

Knowledge of GDM pathogenesis remains incomplete. We studied if serum ADM levels are elevated in subjects with GDM and assessed its possible inhibitory effects on insulin secretion.

Diana L Alba and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 711–720, https://doi.org/10.1210/jc.2018-00952

Despite declines in lean mass and absolute muscle strength, relative muscle strength and physical performance significantly improved in adults with morbid obesity after Roux-en-Y gastric bypass surgery.

Jane Rigg and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 721–729, https://doi.org/10.1210/jc.2018-01104

Maternofetal outcomes of medical and surgical management were compared. Rates of preeclampsia and preterm delivery were higher in medically treated patients. The study was limited by its small size.

Justin B Echouffo-Tcheugui and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 738–752, https://doi.org/10.1210/jc.2018-01321

An investigation during two decades shows that metabolically health obesity is dynamic, and over time individuals with the condition develop metabolic abnormalities and clinical disease.

Pauline Romanet and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 753–764, https://doi.org/10.1210/jc.2018-01170

The French TENGEN network has interpreted 370 MEN1 variants and registered 1676 MEN1-positive patients in the UMD-MEN1 database. Clinical data were analyzed to determine the patients’ outcomes.

Robert F Harrison and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 765–772, https://doi.org/10.1210/jc.2018-01172

Accepting that most people sleep 7 to 8 hours, ∼8-hourly salivary cortisone measurements provide a noninvasive method of estimating 24-hour cortisol exposure in population studies.

Megan R Haymart and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 785–792, https://doi.org/10.1210/jc.2018-01933

Over time an increase in area-level use of thyroid ultrasound as initial imaging has been associated with an increase in thyroid cancer incidence, including incidence of low-risk thyroid cancer.

Petra Hanson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 793–800, https://doi.org/10.1210/jc.2018-00578

This is a report of application of mindfulness strategies in the context of a tier 3 obesity service in the United Kingdom demonstrating its efficacy for positive change in eating-related behaviors.

Alessandro Ciresi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 801–808, https://doi.org/10.1210/jc.2018-01440

Irisin was evaluated in prepubertal children with GHD at baseline and during 12 months of GH treatment, showing a significant increase in its levels mainly correlated to the change in BMI and IGF-I levels.

Jacob P Christ and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 809–818, https://doi.org/10.1210/jc.2018-01787

Preconception data, among women with PCOS, were used to predict adverse obstetric and perinatal outcomes. Hyperandrogenism and markers of glucose regulation were key predictors of adverse outcomes.

Liesa Ilg and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 827–834, https://doi.org/10.1210/jc.2018-01566

This study demonstrates an increased cortisol secretion in response to a psychosocial stressor following antenatal synthetic glucocorticoid therapy that persists from childhood into adolescence.

Ralph Decker and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 835–844, https://doi.org/10.1210/jc.2018-01006

In a hypothesis-driven randomized clinical trial after CUG with GH treatment, a 50% reduction of an individualized GH dose maintained channel parallel growth (i.e., normal height velocity).

Katharina Warncke and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 845–855, https://doi.org/10.1210/jc.2018-01696

We investigated patients with rare diabetes forms HNF4A-MODY (n = 44) and HNF1B-MODY (n = 35) in the DPV registry and characterized phenotype and treatment of these two rare forms of MODY diabetes.

Carla Scaroni and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 856–862, https://doi.org/10.1210/jc.2018-01360

The GH response to OGTT may reflect the underlying biological heterogeneity of somatotropinomas and describe its predictive role on somatostatin analogue response in acromegaly.

Trond M Michelsen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 873–882, https://doi.org/10.1210/jc.2018-01154

Placental glucose consumption significantly influenced maternal–fetal glucose transfer in healthy human pregnancies.

Wadim M I de Boon and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 883–891, https://doi.org/10.1210/jc.2018-01364

A first-in-human trial was performed with a novel somatostatin-dopamine chimeric compound, BIM23B065. BIM23B065 was able to reduce GH and prolactin levels in healthy volunteers.

Joseph M Kindler and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 892–899, https://doi.org/10.1210/jc.2018-00353

Insulin resistance and adiposity are negative predictors of bone mass. In the present study, the inverse relationship between adiposity and bone was mediated through insulin resistance.

Juan Tiraboschi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 900–905, https://doi.org/10.1210/jc.2018-01489

We describe changes in body fat distribution (BFD) occurring in ART-naive patients starting different regimens. Current antiretroviral regimens have little impact on BFD during the first years of treatment.

Geoffrey D Miller and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 906–914, https://doi.org/10.1210/jc.2018-01159

Clomiphene was administered to male recreational athletes for 1 month. Testosterone levels increased during treatment, and drug use was evident via urinary detection for >9 months after use.

Ammar Muhammad and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 915–924, https://doi.org/10.1210/jc.2018-01524

We found that the IGF-I lowering of pasireotide LAR correlated with that of first-generation SRLs in acromegaly. Both treatments were correlated to SSTR2 protein expression on somatotroph adenomas.

Frank González and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 934–946, https://doi.org/10.1210/jc.2018-01143

We studied the effect of lipid on LPS-mediated inflammation and TNFα-mediated IR in PCOS. We found an obesity-related LPS response worsened by PCOS and an obesity-independent mechanism of IR in PCOS.

Risa M Wolf and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 947–956, https://doi.org/10.1210/jc.2018-02245

We measured 76 cytokines in obese and lean patients and in obese patients after bariatric surgery. Thirteen cytokines were higher and four lower in obesity. Soluble vascular endothelial growth factor receptor 2 decreased and chemokine (C-X-C motif) ligand 12 increased with surgery.

Gabrielle Page-Wilson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 961–969, https://doi.org/10.1210/jc.2018-01909

Plasma AgRP levels are elevated in CD, are strongly correlated with cortisol concentrations, and decline following curative transsphenoidal surgery.

Sinnie Sin Man Ng and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 970–980, https://doi.org/10.1210/jc.2018-01216

AKAP13 was bound to PRB and augmented progesterone-dependent gene activation via an ERK-dependent mechanism in uterine fibroid cells.

Commentaries

Robert M Cohen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 707–710, https://doi.org/10.1210/jc.2018-02409

Commentary placing genetic ancestry markers and racial difference in HbA1c in the context of more common variations in the HbA1c-average glucose relationship and their clinical implications.

Marissa Black
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 864–866, https://doi.org/10.1210/jc.2018-02551

Commentary on a report of the application of mindfulness strategies within a “tier 3” multidisciplinary weight loss program to improve eating behaviors and facilitate weight loss.

Letters to the Editor

Adam Hulman and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 674–675, https://doi.org/10.1210/jc.2018-01699
Teresa Vanessa Fiorentino and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 676–677, https://doi.org/10.1210/jc.2018-01824
Patricio H Contreras and Pilar Vigil
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 678–679, https://doi.org/10.1210/jc.2018-01598
Grace Huang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 680–681, https://doi.org/10.1210/jc.2018-02015
Kamyar Asadipooya
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 682–683, https://doi.org/10.1210/jc.2018-02066
Lydia S Lamb and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 684–685, https://doi.org/10.1210/jc.2018-02198
Michael K Laidlaw and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 686–687, https://doi.org/10.1210/jc.2018-01925
Tanya Reznick and Daniel J Rubin
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 730–731, https://doi.org/10.1210/jc.2018-01629
Esmeralda Capristo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 732–733, https://doi.org/10.1210/jc.2018-01813
Andrea Salzano and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 734–735, https://doi.org/10.1210/jc.2018-02043
Milos Brankovic and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Pages 736–737, https://doi.org/10.1210/jc.2018-02149

Correction

The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 3, March 2019, Page 863, https://doi.org/10.1210/jc.2019-00121
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close